<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=4423596&amp;fmt=gif">
Discover AGCellerate™ for LVV - a faster option to get your GMP-ready lentiviral vector product   Learn about AGCellerate

Accelerating CGT with plug-and-play viral vectors-download-graphic


Accelerating CGT with Plug-and-Play Viral Vectors


With a surge in demand for high-quality clinic-ready viral vectors and the increase in cell and gene therapies gaining more popularity, we see a rising need for developers to find ways to accelerate their development process. Standardized plug-and-play manufacturing platforms could revolutionize viral vector production by effectively expediting product development timelines while being flexible enough to account for each products specific requirements.

Key Takeaways

  • How templated platforms can get products to GMP in half the time

  • Establishing platform processes

  • How a global manufacturing partner can help ensure commercialization success